​***If you do not receive your event confirmation within 1 business day of RSVPing (above), check your email spam folder. The automated Luma email includes the Zoom info and cal invite.***

​This Comm Convo is FREE for all T2B members!

​If you're not part of Ticket to Biotech, confirm you're eligible, and join before registering for this event:

​T2B Intake Form

​DECEMBER COMM CONVO: T2B WRAPPED 2025 + WHAT'S NEXT

​We're delivering our own version of "T2B Wrapped" and pulling back the curtain on our remarkable 2025 journey with real data, member stories, and an exclusive preview of what's ahead. We've grown to 1,300 members globally representing every major biopharma hub in the US and beyond, but the impact goes deeper than numbers—it's the breakthrough moments, the reunions with former colleagues, the career pivots, and the connections that have fundamentally changed how we approach our profession. Throughout this year we've gathered feedback, analyzed the landscape, and listened closely to understand what our community truly needs and values. In this special Comm Convo, we'll reveal updated member growth metrics, survey data from this year's programs, and insights into how we've bootstrapped this business over two years as we build toward sustainability. Join us for this celebration as we unveil our 2026 roadmap, including next year's Biopharma Comms Forum theme and the monthly topics that will continue to elevate our profession.

​WHY ATTEND

• ​Hear firsthand from members whose T2B connections created real career impact, from landing new roles to transforming their strategic approach to communications leadership and elevating their executive influence.

• ​Discover the inside story on T2B's path to sustainability, including our bootstrap business model, key lessons learned from building without traditional funding, and surprising data behind T2B's community growth.

• ​Be the first to see our 2026 programming roadmap as we unveil our new forum theme, monthly Comm Convo topics, and the launch of our newest member-led roundtable designed to tackle our profession's biggest challenges.

• ​Celebrate alongside community members as we witness how individual success stories reflect our collective journey in elevating and reshaping the biopharma communications profession for 2026 and beyond.

​MEET OUR SPEAKERS

​Mary Carmichael, Head of Science & Technology Communications, Danaher Corporation

​Mary Carmichael, MBA, leads science and technology communications at Danaher, where she helps translate complex innovation in life sciences, diagnostics, biomanufacturing, and AI into clear, compelling stories. She previously held communications leadership roles at Novartis and the Broad Institute of MIT and Harvard, where she also led efforts in data-sharing for therapeutics development. A former science journalist for Newsweek and the Boston Globe, Mary is passionate about making emerging technologies accessible and meaningful to the public, journalists and policymakers alike.

​

​Marisa Sharkey, Senior Director, Corporate Communications, Harmony Biosciences

​Marisa Sharkey, MA, APR is an award-winning communications executive with 20+ years of success leading integrated external, internal and digital communications including public relations and corporate reputation and brand functions within the pharmaceutical, biotech and healthcare industries. Her expertise encompasses strategic direction and planning, corporate reputation including top-tier media relations, stakeholder engagement, issues management, and change management in highly matrixed organizations.

​

​Matt Worrall, Global Director of Corporate Communications - Reproductive Medicine and Global Stakeholder Relations, Ferring Pharmaceuticals

​Matt Worrall has been in working in healthcare and life science communication for more than 20 years for a wide range of organisations including charities, trade associations and medical societies before switching to work for pharma and biotech for AbbVie, Merck & co (MSD) and now Ferring. Matt is passionate about the important role industry must play in supporting health literacy and accessible information for all. He works to develop the strategic impact pharma communicators can have through stakeholder engagement, story telling, policy development and adoption of media technology.